MedTrace Logo

Remote Delivery of Weight Management for Adults With IDD

NCT03291509 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-03-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare different weight loss programs in people with IDD to see which program works better.

Conditions

Interventions

BEHAVIORAL

Video Conference Meetings

Individual video conferencing with a health educator using an iPad.

BEHAVIORAL

In-person Meetings

Individual face-to-face (FTF) meetings with a health educator.

BEHAVIORAL

Enhanced Stop Light Diet

Diet composed of healthy, pre-packaged meals, balance of fruits, vegetables, and low calories snacks, and shakes. Participants and study partners will be trained to use a color coded chart which categorize foods based on the Stop Light system (green, yellow, red) to assist in meal planning, grocery shopping, decisions regarding snack foods, and compliance with the diet in special situations such as eating away from home (restaurants, parties, etc.).

BEHAVIORAL

Physical Activity

Participants will be asked to complete a set amount of time of moderate-to-vigorous physical activity each week. Participants in the Computer group will be asked to attend remote exercise sessions 2 times a week.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Joseph Donnelly, PhD · University of Kansas Medical Center

  • Lauren T Ptomey, PhD, RD, LD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-21
Primary Completion
2021-03-16
Completion
2022-08-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03291509 on ClinicalTrials.gov